Global Coronary Stent Systems Market Size By Type (Bare Metal Stents, Drug-Eluting Stents), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Coronary Stent Systems Market was valued at USD 11.1 billion in 2023 and is projected to reach USD 20.4 billion by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. This growth is fueled by the increasing prevalence of cardiovascular diseases (CVDs), growing aging population, technological advancements in stent design, and the expanding number of percutaneous coronary intervention (PCI) procedures globally. Coronary stent systems, vital for restoring blood flow in narrowed arteries, continue to evolve with innovations such as bioresorbable scaffolds and drug-eluting stents (DES), enhancing patient outcomes and driving market expansion.

Drivers:

1. Rising Incidence of Cardiovascular Diseases:

The increasing global burden of coronary artery disease and other heart-related conditions is significantly boosting the demand for effective interventional treatments, particularly stent placements.

2. Technological Advancements in Stent Systems:

Developments such as biodegradable stents, dual-therapy stents, and polymer-free DES are offering improved clinical outcomes, spurring their adoption.

3. Expanding Geriatric Population:

A growing elderly population, more susceptible to coronary conditions, is contributing to the rise in stent implantation procedures.

Restraints:

1. High Cost of Advanced Stents and Procedures:

While technologically superior, newer-generation stents are expensive, which can limit accessibility, especially in price-sensitive or underdeveloped healthcare systems.

2. Stringent Regulatory Requirements:

Coronary stents are classified as high-risk medical devices, requiring rigorous testing and compliance. These stringent regulations can slow down product approval and market entry.

Opportunity:

1. Growth in Emerging Markets:

Rising healthcare infrastructure investments, increasing awareness of heart health, and a growing middle class in Asia-Pacific and Latin America present strong opportunities for market players.

2. Focus on Minimally Invasive Interventions:

The global shift toward minimally invasive procedures, combined with patient preference and quicker recovery times, is favoring the adoption of advanced coronary stent systems.

Market by System Type Insights:

By system type, Drug-Eluting Stents (DES) dominated the market in 2023, owing to their proven efficacy in reducing restenosis rates compared to bare-metal stents. Bioabsorbable stents are gaining traction and expected to register the fastest growth during the forecast period due to their potential to eliminate long-term complications associated with permanent implants.

Market by End-use Insights:

In terms of end-use, Hospitals accounted for the largest revenue share in 2023 due to the high number of PCI procedures performed in these facilities. The Cardiac Centers segment is anticipated to witness substantial growth, propelled by the increasing number of specialized heart care facilities and rising investments in medical infrastructure.

Market by Regional Insights:

North America led the coronary stent systems market in 2023, driven by high healthcare expenditure, advanced medical infrastructure, and early adoption of innovative stent technologies. However, the Asia-Pacific region is expected to grow at the fastest rate through 2031, supported by rising CVD incidence, expanding healthcare access, and growing medical tourism.

Competitive Scenario:

Key market players include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, Cook Medical, and MicroPort Scientific Corporation. These companies are focusing on launching next-generation stents, obtaining regulatory approvals, and expanding in high-growth emerging regions.

Key Developments:

In 2023, Abbott received expanded FDA approval for its next-gen drug-eluting stent featuring enhanced deliverability and long-term outcomes.

In 2024, Boston Scientific announced global launch plans for its bioresorbable vascular scaffold with next-gen polymer technology.

Medtronic launched a new portfolio of coronary stents in Asia-Pacific to tap into the region’s expanding cardiovascular care market.

Scope of Work – Global Coronary Stent Systems Market

Report Metric Details

Market Size (2023) USD 11.1 billion

Projected Market Size (2031) USD 20.4 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (DES, BMS, Bioresorbable), By End-use (Hospitals, Cardiac Centers), By Region

Growth Drivers Rising cardiovascular disease prevalence, aging population, and technological advancements

Opportunities Emerging markets growth, demand for minimally invasive procedures

FAQs:

1) What is the current market size of the Global Coronary Stent Systems Market?

The market size was valued at USD 11.1 billion in 2023.

2) What is the major growth driver of the Global Cor